Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study

• Ye-Jee Kim,
• Min Jae Kim,
• Jiwon Jung,
• Sung-Han Kim,
• Seongman Bae,
• Min-ju Kim,
• Jwa Hoon Kim,
• Yong Pil Chong,
• Sang-Ho Choi,
• Yang Soo Kim,
• Sang-Oh Lee

Affiliations

Ye-Jee Kim

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Min Jae Kim

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Jiwon Jung

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Sung-Han Kim

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Seongman Bae

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Min-ju Kim

Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Jwa Hoon Kim

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Yong Pil Chong

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Sang-Ho Choi

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Yang Soo Kim

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Sang-Oh Lee

Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea